Skip to Main Content
Table 1.

APN/CD13 expression on the lung cancer cell lines by flow cytometry analysis and RT-PCR

NSCLCFACSRT-PCRSCLCFACSRT-PCR
LCMS (AD) SBC1 (SCLC) 
MAC10 (AD) SBC2 (SCLC) 
PC9 (AD) SBC3 (SCLC) 
PC14 (AD) SBC5 (SCLC) 
A549 (AD) MOA1P23 (SCLC) 
HAL8 (AD) LU135 (SCLC) 
HAL24 (AD) LU139 (SCLC) 
ABC1 (AD) N417 (SCLC) 
LC-2/ad (AD) Lawson (SCLC) 
LC-1/sq (SQ) SCLC-Mo (SCLC) 
EBC1 (SQ) LCMA (SCLC) 
LC-TK (SQ)    
LC1F (SQ)    
AOI (SQ)    
EHHSQ13 (SQ)    
LK-1 (SQ)    
NSCLCFACSRT-PCRSCLCFACSRT-PCR
LCMS (AD) SBC1 (SCLC) 
MAC10 (AD) SBC2 (SCLC) 
PC9 (AD) SBC3 (SCLC) 
PC14 (AD) SBC5 (SCLC) 
A549 (AD) MOA1P23 (SCLC) 
HAL8 (AD) LU135 (SCLC) 
HAL24 (AD) LU139 (SCLC) 
ABC1 (AD) N417 (SCLC) 
LC-2/ad (AD) Lawson (SCLC) 
LC-1/sq (SQ) SCLC-Mo (SCLC) 
EBC1 (SQ) LCMA (SCLC) 
LC-TK (SQ)    
LC1F (SQ)    
AOI (SQ)    
EHHSQ13 (SQ)    
LK-1 (SQ)    

Abbreviations: AD, adenocarcinoma; SQ, squamous cell carcinoma; LA, large cell carcinoma; W, weak (<20%); M, moderate (21-60%); S, strong (>61%); N, negative; P, positive; FACS, fluorescence-activated cell sorting analysis.

Close Modal

or Create an Account

Close Modal
Close Modal